ProMIS Neurosciences Initiates Phase 1b Clinical Trial (PRECISE-AD) in Alzheimer’s Disease
Go back to ProMIS Neurosciences Initiates Phase 1b Clinical Trial (PRECISE-AD) in Alzheimer’s Disease| Imperial Petroleum, Inc. (NASDAQ: PMN) | Delayed: 12.90 -1.08 (7.73%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.98 | 52 Week High | $0.05 | |||
| Open | $13.90 | 52 Week Low | $0.05 | |||
| Day High | $14.16 | P/E | N/A | |||
| Day Low | $12.76 | EPS | $0.00 | |||
| Volume | 37,395 | |||||
